--(BUSINESS WIRE)--Biotechnology Innovation Organization (BIO):
WHAT: |
Representatives from venture capital and private equity firms will provide insight on investing in innovative growth companies in the industrial biotechnology sector who are developing biofuels, renewable chemicals, and biobased products platforms. The teleconference is open to early-stage industrial biotechnology companies and reporters. | |
WHO: |
Roger Wyse, Managing Partner, Spruce Capital Partners; |
|
Thomas Huot, Managing Director, VantagePoint Capital Partners; |
||
Daniel Auriel, Investment Manager, Capricorn Venture Partners; |
||
John May, Managing Director, Stern Brothers & Co.; |
||
Jason Webber, Principal, Sustainable Conversion Ventures; |
||
Mario Portela, Managing Director, TPG. |
||
WHEN: |
Tuesday, July 12, 2016. 1:30pm – 2:30pm ET | |
RSVP: |
Reporters may access the teleconference through an Operator Assisted Toll-Free Dial-In Number. To reserve space, please contact Paul Winters, Communications Director, BIO at 202-962-9237 or pwinters@bio.org. |
About BIO
BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO’s blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
Upcoming BIO Events
September 21-23, 2016 Bethesda, MD |
BIO IP & Diagnostics Symposium September 29, 2016 Alexandria, VA |
|||
October 18-19, 2016 San Francisco, CA |
October 26-28, 2016 |